ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Hospitalist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,340Medicare Part D Prescriptions Filled, Including Refills
$706K Total Retail Price of All Prescriptions
576 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LISINOPRIL 518 460
HYDROCODONE-ACETAMINOPHEN 456 310 S3
LEVOTHYROXINE SODIUM 431 394
SIMVASTATIN 397 363
OMEPRAZOLE 328 279
AMLODIPINE BESYLATE 302 283
METFORMIN HCL 274 253
ZOLPIDEM TARTRATE 211 168
FUROSEMIDE 201 174
CITALOPRAM HBR 183 152
HYDROCHLOROTHIAZIDE 173 165
PRAVASTATIN SODIUM 154 120
WARFARIN SODIUM 148 134
METOPROLOL TARTRATE 146 140
CARVEDILOL 143 117
LOSARTAN POTASSIUM 127 113
ATENOLOL 120 105
DONEPEZIL HCL 118 118
POTASSIUM CHLORIDE 116 100
DOXAZOSIN MESYLATE 112 104
TRAMADOL HCL 104 88
ATORVASTATIN CALCIUM 103 98
GABAPENTIN 96 74
METOPROLOL SUCCINATE 94 84
SERTRALINE HCL 89 81
CLOPIDOGREL 88 78
PROAIR HFA 83 78
NAMENDA 76 76
LOVASTATIN 73 73
TIZANIDINE HCL 67 57
LANTUS SOLOSTAR 65 61
FELODIPINE ER 65 65
MORPHINE SULFATE ER 64 15 S2
CARISOPRODOL 63 0 R
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 49
RANITIDINE HCL 61 45
ADVAIR DISKUS 61 47
ALLOPURINOL 60 45
CRESTOR 57 45
FLUTICASONE PROPIONATE 57 55
PLAVIX 57 53
GLIPIZIDE 55 46
CLONIDINE HCL 55 55
PREDNISONE 54 47
ACTOS 54 46
TRAZODONE HCL 54 26
SPIRIVA 54 52
BUPROPION HCL SR 53 45
SINGULAIR 52 49
MELOXICAM 51 45
FLUOXETINE HCL 51 45
ISOSORBIDE MONONITRATE ER 51 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.